Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Direxion Daily Semiconductor Bear 3X Shares (SOXS) vs GeneDx Holdings Corp (WGS) Price & Performance

Direxion Daily Semiconductor Bear 3X SharesTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Direxion Daily Semiconductor Bear 3X Shares vs GeneDx Holdings Corp — how do they compare? Direxion Daily Semiconductor Bear 3X Shares trades at $44.86, while GeneDx Holdings Corp trades at $86.53 (market cap $2.58B). Which is the better fit depends on your goals.

SOXSWGS
Sector
Leveraged / InverseTechnology
52-Week High
$1.29K$167.51
52-Week Low
$32.50$34.51
Market Cap
$2.58B
Enterprise Value
$2.61B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Direxion Daily Semiconductor Bear 3X Shares

SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $44.09, down 4.86% in the past 24 hours amid a bearish technical signal. The stock is approaching key support at $43 after a 1:10 stock split effective July 15, 2026. Recent news highlights its volatility as an inverse ETF benefiting from semiconductor sector weakness, though technical indicators show mixed signals with RSI neutral and ADX suggesting a weakening trend.

The outlook remains highly speculative due to SOXS's leveraged inverse structure, which amplifies losses in rising markets. Risks include persistent AI-driven semiconductor demand and the ETF's decay over time. It is suited only for short-term tactical bearish bets, not long-term investment, with current sentiment cautioning against entry without clear technical breakdowns.

GeneDx Holdings Corp

WGS trades at $85.87, down 0.14% on the day, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4 million, beating estimates, and achieved adjusted profitability ahead of schedule. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics, driving positive sentiment.

Outlook is cautiously optimistic due to strong analyst support (90.9% buy ratings) and revenue growth, but risks include negative net income margins, high valuation multiples, and ongoing class action lawsuits. The stock's upside potential hinges on sustained operational improvements and market expansion in genomics diagnostics.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Direxion Daily Semiconductor Bear 3X Shares

SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.

Read more on SOXS

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS